Durability of clinical responses to anti-HIV therapies.
作者信息
Laurence Jeffrey
出版信息
AIDS Read. 2008 Mar;18(3):120-1.
PMID:18398977
Abstract
摘要
相似文献
1
Durability of clinical responses to anti-HIV therapies.
AIDS Read. 2008 Mar;18(3):120-1.
2
Inadvertent non-nucleoside reverse transcriptase inhibitor (NNRTI)-based antiretroviral therapy in dual HIV-1/2 and HIV-2 seropositive West Africans: a retrospective study.
J Antimicrob Chemother. 2009 Sep;64(3):667-9. doi: 10.1093/jac/dkp216. Epub 2009 Jun 23.
3
Mortality among urban drug users and the impact of highly active antiretroviral therapy.
Clin Infect Dis. 2005 Sep 15;41(6):873-4. doi: 10.1086/432895. Epub 2005 Aug 16.
4
Interleukin 2 and HIV RNA Levels.
Arch Intern Med. 2007 Oct 22;167(19):2144-5; author reply 2145. doi: 10.1001/archinte.167.19.2144-b.
5
HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy.
AIDS. 2008 Aug 20;22(13):1583-8. doi: 10.1097/QAD.0b013e328305bd77.
6
Immunovirological and therapeutic follow-up of HIV-1/HIV-2-dually seropositive patients.
AIDS. 2009 Jan 28;23(3):426-8. doi: 10.1097/QAD.0b013e328321305a.
7
Comparative mortality in HIV-infected patients in Denmark, 1995-2005.
J Insur Med. 2008;40(2):116-9.
8
Sustained immunological responses to highly active antiretroviral therapy at 36 months in a Ghanaian HIV cohort.
Clin Infect Dis. 2009 Apr 1;48(7):988-91. doi: 10.1086/597353.
9
The good, the bad, and the ugly: providing highly active antiretroviral therapy when it is most difficult.
Clin Infect Dis. 2006 Jun 1;42(11):1636-8. doi: 10.1086/503916. Epub 2006 Apr 28.
10
HIV infection in older patients.
Clin Infect Dis. 2003 May 15;36(10):1347. doi: 10.1086/374871.
Zotero 插件